Indian pharma company in pact with Swiss firm to sell 7 generic drugs in Singapore, Thailand

📆 22/06/2020 16:02:00
📰 staronline

⏱ Reading Time:
23 sec. here
2 min. at publisher
📊 Quality Score:
News: 13%
Publisher: 75%

Italia Notizia Notizia

Italia Ultime Notizie,Italia Notizie

MUMBAI/SINGAPORE (Xinhua): India's Biocon Pharma and Swiss Market Expansion Services Group DKSH on Monday (June 22) have entered into a collaboration wherein the latter will sell and distribute seven of Biocon's generic formulations in Singapore and Thailand, a Biocon statement said.

As part of the agreement, Zurich headquartered DKSH will gain an exclusive license to register and commercialize these seven generic formulations from various therapeutic areas like diabetology, cardiology, oncology and immunology, which will be sold under Biocon's brand.

"This collaboration will enable us to address the growing patient needs for affordable access to high-quality generics for chronic diseases and expand our commercial footprint in this region," said Siddharth Mittal, CEO & Managing Director, Biocon, with annual revenues of 837.5 million U.S. dollars. "Together with Biocon Pharma, we can help a lot of patients in Asia who require advanced therapies for chronic diseases."

Scrivi un Commento

Abbiamo riassunto questa notizia in modo che tu possa leggerla velocemente. Se sei interessato alla notizia puoi leggere il testo completo qui. Leggi di più:

Italia Ultime Notizie, Italia Notizie

Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.

Indian company launches drug to treat mild, moderate Covid-19 patients; another gunfight breaks out in KashmirMUMBAI (Xinhua): Glenmark Pharmaceuticals has become the first Indian company to launch anti-viral drug Favipiravir for the treatment of mild to moderate Covid-19 patients in the domestic market following the manufacturing approval from the drug regulator, a company statement said.
Fonte: staronline - 🏆 4. / 75 Leggi di più »